As of 2021, very few of these technologies had been reviewed and accredited by bodies such as the Organisation for the Review of Care and Health Apps (ORCHA), with fewer still meeting ORCHAs quality threshold, assessed across a range of domains, including clinical assurance, data privacy, and user experience (figure 6)
Researchers use AI to surface unreported GLP-1 side effects in Reddit posts An AI analysis of more than 400,000 Reddit posts found discussions of menstrual changes, fatigue and temperature-related complaints that may not be fully captured in clinical trials or drug labeling
The report offers the value (in USD) and volume (in units) for the above segments
In response, AOD-9604Peptide.com has released its new 2026 AOD-9604 Consumer Insight Report, offering a clear breakdown of the most commonly misunderstood aspects of the peptide including benefits, side effects, dosage discussions, and key points emerging from early research
The GLP-1 market alone is reshaping commercial forecasting conventions: Novo Nordisks semaglutide (Ozempic/Wegovy) generated over $10B in 2023 revenue, a figure that would have been considered unreachable for a single molecule five years ago
